eBizNET has entered into a strategic relationship with CDC Software, which is expected to accelerate the deployment of its SaaS supply chain systems in emerging, high growth markets.
Ajinomoto AminoScience has launched AjiPhase, a peptide synthesis service which makes it practical and efficient to produce and scale up products that were previously considered too complex.
Demand in “Pharmerging” markets will offset declining revenues from off-patent blockbusters and drive prescription drug sales to $1.1tr (€819bn) by 2014, according to IMS Health.
Sandoz will buy generics firm Oriel Therapeutics, adding the US company’s FreePath delivery system and Solis multi-dose dry powder inhaler to its respiratory drug technology portfolio.
MLawGroup and WS Partners are collaborating to offer pharma and biotech advisory services, including help in preparing and negotiating agreements with CROs and CMOs.
PRA has expanded into New Zealand, complementing its Asia-Pacific network and establishing a point of contact for pharmas interested in benefiting from the county’s high recruitment rates.
Charles River Laboratories’ (CRL) Shanghai preclinical test facility GLP certified by Belgian authorities under the OECD’s mutual acceptance of data framework.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Baxter, Dendreon, Roche, Somaxon and Silence Therapeutics.
IT giant Oracle will pay $685m (€507m) for eClinical solutions firm Phase Forward, significantly expanding its presence in the billion dollar contract clinical research sector.
Baxter’s BioPharma Solutions unit has expanded its manufacturing facility in Halle, Germany, adding capacity to meet clients’ demand for large-scale production of cytotoxics.
The EFPIA has hailed its 2-D data matrix anti-counterfeiting pilot scheme as a success and hopes to convince governments and supply chain actors of benefits of the approach.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including Frontage hiring to launch its DMPK unit and appointments at Patheon and Atacama Labs Oy.
in-PharmaTechnologist presents exclusive interactive maps of pharma manufacturing facilities in India, detailing the number of bulk drug and formulation facilities in each region of the country.
The US Food and Drug Administration (FDA) has issued Apotex with another warning letter about cGMP violations at two plants explaining the firm’s response to previous warnings “is inadequate and lacks sufficient corrective actions.”
ePharmaSolutions has launched Clinical Trial Portal (CTP) 4.0, adding new capabilities including electronic monitor visit report (eMVR) and improved site feasibility application (SFA).
“Good business development” in the pharma and “slow spending” in the cyclical cosmetics and life sciences sectors dominated Gerreshimer’s performance in the first quarter of 2010.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Xcellerex, Bristol-Myers Squibb and KV Pharmaceutical.
Perceptive Informatics has added industry standard performance metrics to its medical imaging capabilities, allowing users to track progress against Metrics Champion Consortium (MCC) criteria.
Contract manufacturing organisation (CMO) Patheon has installed new soft gel manufacturing capacity at its facility in Cincinnati in response to “an unmet customer need.”
Canada made a “value judgement” in dropping its plans for a HIV vaccine plant, according to a representative of the public health agency who said the money could be better spent in other areas.
Hong Kong, China-based drug wholesaler Julius Chen & Co has been ordered to recall 300mg/tablet formulation of a gout treatment name Puricos (allopurinol) after DoH officials discovered the firm packaged it without a license to do so.
Archimica has entered into an exclusive distribution agreement with a Merck KGaA subsidiary to provide building blocks and special reagents for organic synthesis.
Rising use of biologics and a tax initiative will drive the streamlining of Indian supply chains, helping companies to deliver drugs at affordable prices, according to PwC.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at LAB Research, PBI, CRF Health and US Data Management.
Russia, the Ukraine and Belarus have emerged as destinations for clinical studies and now offer “enormous” potential according to US-based CRO ClinStar.
ClearTrial has launched an upgrade to its clinical trial operations (CTO) software, adding more country specific knowledge, such as labour rates, to help companies forecast costs and timelines.
US delivery specialist Penwest is to apply its Timerx tech to “complex” generic pharmaceuticals in a development and commercialisation pact with non-branded drugmaker Alvogen.
DiscoveRx has added GPCR platforms to its portfolio, enhancing its ability to provide information on a compound’s mode of action, activated receptor recycling and efficacy in animal models.
Amcor Flexibles has expanded its drug packaging capacity with the installation of a new blown-film production line at its facility in Mundelein, Illinois, US.
The drug industry will gain new options for sterile contract development and manufacturing in the near future with DPT Laboratories, NextPharma and Vetter each working on new dedicated units.
Winsunny Pharma has exclusively licensed NMT’s HGCP technology, which produces APIs in low micron and nano-sized range, to manufacture a hyperlipidemia-controlling drug in China.
Aris Global has introduced Total Clinical 2.0, a software package which integrates EDC, safety and adverse event systems to streamline operations and cut costs.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Clearstone Central Laboratories, NexMed and RRD.
US biotechnology company Genentech presents new $400m pharmaceutical manufacturing and distribution facility in Hillsboro, Oregon and says construction is nearly complete.
in-PharmaTechnologist presents its weekly round up of movements in the pharma sector, including appointments at Genzyme, PharmAthene and Cadence Pharmaceuticals.
Chiltern has invested in endpoint to establish a strategic relationship which allows it to offer an IRT capable of cutting timelines and costs, a company EVP told Outsourcing-Pharma.
